Statistics > Applications
[Submitted on 28 Aug 2018 (v1), revised 16 Nov 2021 (this version, v13), latest version 10 Jan 2022 (v15)]
Title:The efficacy of an intervention can be assessed by randomizing to different diagnostic testing strategies and solving simultaneous equations: Required when assessing the effectiveness of test, trace and isolation
View PDFAbstract:The efficacy of an intervention can be assessed by randomising patients to different diagnostic tests instead of directly to an intervention and control. This allows the probability of an outcome to be estimated conditional on the intervention and control and thus also the odds ratio (OR) and risk reduction (RR). The tests must have different characteristics (e.g. sensitivities) with respect to the outcome. This principle is applied by allocating an intervention if the test result is positive but allocating to a control if the result is negative. This can also be done with different dichotomising thresholds for one test. The frequencies of the outcome in those with each of the four resulting observations are then used to calculate the RR and OR by solving a pair of simultaneous equations. This assumes that the RR and OR due to intervention compared to control are the same in both test groups. The calculations are illustrated by using data from a randomized controlled trial (RCT) that assessed the efficacy of an angiotensin receptor blocker (ARB) in lowering the risk of diabetic nephropathy in patients conditional on urinary albumin excretion rates (AERs). The calculations are also illustrated with simulated data for assessing the effectiveness of test, trace and isolation to reduce transmission of the SARS-Cov-2 virus by randomising to RT-PCR or LFD tests. This approach allows the sensitivity, specificity, of these tests with respect to viral spreading to be determined. The individual results of can be used to assemble curves displaying the probability of an outcome on intervention and control conditional on the measurement results by fitting spline functions. This is demonstrated using the data from the above RCT on assessing the probability of nephropathy conditional on an AER with ARB or placebo.
Submission history
From: Huw Llewelyn Dr [view email][v1] Tue, 28 Aug 2018 08:40:18 UTC (288 KB)
[v2] Mon, 22 Jul 2019 10:51:47 UTC (297 KB)
[v3] Mon, 9 Sep 2019 09:19:02 UTC (297 KB)
[v4] Wed, 12 Feb 2020 23:59:27 UTC (308 KB)
[v5] Thu, 27 Feb 2020 09:20:56 UTC (328 KB)
[v6] Tue, 26 Jan 2021 23:52:11 UTC (448 KB)
[v7] Thu, 28 Jan 2021 07:28:14 UTC (447 KB)
[v8] Wed, 3 Feb 2021 22:46:53 UTC (452 KB)
[v9] Sat, 17 Apr 2021 22:43:05 UTC (306 KB)
[v10] Thu, 22 Apr 2021 10:09:11 UTC (307 KB)
[v11] Tue, 11 May 2021 23:25:02 UTC (514 KB)
[v12] Sun, 5 Sep 2021 15:59:18 UTC (405 KB)
[v13] Tue, 16 Nov 2021 22:07:09 UTC (453 KB)
[v14] Thu, 9 Dec 2021 16:57:12 UTC (407 KB)
[v15] Mon, 10 Jan 2022 17:31:29 UTC (434 KB)
References & Citations
export BibTeX citation
Loading...
Bibliographic and Citation Tools
Bibliographic Explorer (What is the Explorer?)
Connected Papers (What is Connected Papers?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)
Code, Data and Media Associated with this Article
alphaXiv (What is alphaXiv?)
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Hugging Face (What is Huggingface?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)
Demos
Recommenders and Search Tools
Influence Flower (What are Influence Flowers?)
CORE Recommender (What is CORE?)
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.